Asaf Porat
Director of Finance/CFO chez APPYEA, INC.
Fortune : - $ au 31/03/2024
Profil
Asaf Porat was the founder of Cannibble Foodtech Ltd.
(founded in 2018) and held the title of Chief Financial Officer from 2018 to 2020.
He is currently the Chief Financial Officer & Director at AppYea, Inc., Chief Operating Officer at Outbrain, Inc., and Chief Financial Officer at SleepX Ltd.
(since 2021).
Mr. Porat previously worked as Chairman, President, Chief Executive Officer & CFO at TransAtlantic Capital, Inc. (2011-2014), External Director at Apollo Power Ltd., and Chief Financial Officer at Geneyx Genomex Ltd.
(2019-2021).
He obtained an MBA from Tel-Aviv University in 2007 and an undergraduate degree from Ben-Gurion University of the Negev in 2003.
Détentions connues dans des sociétés publiques
Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
---|---|---|---|---|
APPYEA, INC.
-.--% | 31/03/2024 | 0 ( -.--% ) | - $ | 31/03/2024 |
Postes actifs de Asaf Porat
Sociétés | Poste | Début |
---|---|---|
OUTBRAIN INC. | Chief Operating Officer | 01/05/2018 |
APPYEA, INC. | Director of Finance/CFO | - |
SleepX Ltd.
SleepX Ltd. Information Technology ServicesTechnology Services Part of AppYea, Inc., SleepX Ltd. is a research and development subsidiary that focuses on commercializing its first product, Dreamit. The private company is based in Rehovot, Israel and was founded in 2019 by Ron Mekler and Boris Molchadsky, who has been the CEO since then. The Israeli company has developed a unique product for monitoring and treating sleep apnea and snoring, which is protected by several international patents. The technology uses biofeedback-based therapy to stop snoring and sleep apnea, and provides statistical reports every night. SleepX was acquired by AppYea, Inc. on December 31, 2021. | Director of Finance/CFO | 01/07/2021 |
Anciens postes connus de Asaf Porat
Sociétés | Poste | Fin |
---|---|---|
Geneyx Genomex Ltd.
Geneyx Genomex Ltd. Packaged SoftwareTechnology Services Geneyx Genomex Ltd. engages in the development of artificial intelligence based platform for hospitals, genetic labs, and translational and early target discovery researchers to help in providing diagnoses while reducing turnaround time. Its products include Cloud Update & Data Storage, NGS Pipeline Management, and WGS Interpretation. The company was founded by David Yizhar, Avi Yitzhak, Dvir Dahary, Raviv Itzhaky and Ofer Barnea in 2018 and is headquartered in Herzliya, Israel. | Director of Finance/CFO | 01/06/2021 |
CANNIBBLE FOOD-TECH LTD. | Founder | 01/01/2020 |
TRANSATLANTIC CAPITAL INC. | Chief Executive Officer | 27/05/2014 |
APOLLO POWER LTD | Chairman | - |
Formation de Asaf Porat
Tel-Aviv University | Masters Business Admin |
Ben-Gurion University of the Negev | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 5 |
---|---|
APOLLO POWER LTD | Utilities |
OUTBRAIN INC. | Technology Services |
APPYEA, INC. | Technology Services |
TRANSATLANTIC CAPITAL INC. | Finance |
CANNIBBLE FOOD-TECH LTD. | Consumer Non-Durables |
Entreprise privées | 2 |
---|---|
Geneyx Genomex Ltd.
Geneyx Genomex Ltd. Packaged SoftwareTechnology Services Geneyx Genomex Ltd. engages in the development of artificial intelligence based platform for hospitals, genetic labs, and translational and early target discovery researchers to help in providing diagnoses while reducing turnaround time. Its products include Cloud Update & Data Storage, NGS Pipeline Management, and WGS Interpretation. The company was founded by David Yizhar, Avi Yitzhak, Dvir Dahary, Raviv Itzhaky and Ofer Barnea in 2018 and is headquartered in Herzliya, Israel. | Technology Services |
SleepX Ltd.
SleepX Ltd. Information Technology ServicesTechnology Services Part of AppYea, Inc., SleepX Ltd. is a research and development subsidiary that focuses on commercializing its first product, Dreamit. The private company is based in Rehovot, Israel and was founded in 2019 by Ron Mekler and Boris Molchadsky, who has been the CEO since then. The Israeli company has developed a unique product for monitoring and treating sleep apnea and snoring, which is protected by several international patents. The technology uses biofeedback-based therapy to stop snoring and sleep apnea, and provides statistical reports every night. SleepX was acquired by AppYea, Inc. on December 31, 2021. | Technology Services |